Global site locations
Resilient supply starts with being where you need us—across the U.S.
and the globe
To succeed in today’s complex drug development environment, you need a trusted CDMO partner you can depend on.
We provide industry-leading pharma services through our Patheon™ brand, offering an integrated global network of scientific, technical, regulatory, and quality experts. Our teams are committed to helping you deliver medicines to patients faster. We believe in strategic partnerships founded on science, technology, and world-class expertise—bonded by key elements such as trust, communication, and collaboration.
Resilient supply starts with being where you need us—across the U.S. and the globe.
- We offer supply chain assurance and business continuity during dynamic market conditions.
- Our expanded network and investments guarantee streamlined development and manufacturing.
- We have the capacity, flexibility, and expertise to meet your evolving needs.
Have questions about our U.S. or global capabilities? Contact us.
Comprehensive, connected capabilities across every phase of development
Our pharma services span the full drug development lifecycle—including API, biologics, viral vectors, cell therapies, formulation, clinical trials solutions, logistics services, commercial manufacturing, and packaging. We combine scientific and technical excellence with a collaborative partnership model to support customers of all sizes through every stage of bringing new therapies to patients.
60+ locations
Thermo Fisher Scientific pharma services spans more than 60 sites across 25 countries
560,000+ clinical shipments completed in 2024
Supporting clinical trial execution and accelerating delivery of safe, high-quality medicines
30 purpose-built GMP facilities
A global clinical trial services network built for supply chain support and regulatory compliance
50+ years of CDMO experience
A legacy of scientific partnership and proven development and manufacturing solutions
Our unique global scale and depth
Meeting growing industry demands is our priority. We are continuously expanding capacity and enhancing capabilities across our global facilities to reinforce our commitment to innovation, reliability, and speed. These investments help you navigate supply chain complexities, regulatory challenges, and global economic shifts—ensuring scalable, high-quality manufacturing solutions when and where you need them. With more than 60 locations in over 25 countries, we support every stage of your drug development journey—whether you need to:
- Create or source your API
- Design the ideal formulation
- Scale to your next clinical trial milestone
- Develop a supply chain strategy
- Ensure production continuity
- Launch commercially with confidence
{{ item.title }}
{{ totalVisibleMarkers }} Results found
{{ regionGroup.regionName }}
Featured site: Monza, Italy
Our 642,000 sq ft campus in Monza, Italy is a center of excellence for sterile manufacturing. It features a unique co-location of mRNA manufacturing capabilities with LNP and fill finish services to help streamline your processes and mitigate risk.
Capabilities: Steriles, mRNA
Featured site: Greenville, North Carolina, USA
Our Greenville, NC facility is a large, multipurpose pharmaceutical manufacturing and packaging campus. This site provides both solid dose form manufacturing and packaging and sterile dose manufacturing, filling and lyophilization of both biopharmaceuticals and small molecules.
Capabilities: Steriles
Featured site: Ferentino, Italy
Our Ferentino facility is 14,034 m2 (151,061 ft2), specializing in integrated sterile liquid and lyophilized product development and commercial manufacturing, including high potency products and LVP.
Capabilities: Steriles
Featured site: Groningen, Netherlands
Our Groningen site specializes in cGMP for (pre)clinical and commercial manufacturing, including mammalian cell culture manufacturing, scale up and cGMP manufacturing of recombinant proteins and monoclonal antibodies.
Capabilities: Biologics
Featured site: Lengnau, Switzerland
Our Lengnau facility is a state-of-the-art multipurpose biomanufacturing site in the heart of Europe. This 1.5m sq. ft. facility leverages highly flexible bioproduction technologies, including stainless steel up to 12,500 L bioreactor capability, providing a pathway from development to large-scale production as your manufacturing needs evolve.
Capabilities: Biologics
Featured site: San Francisco, California, USA
Our 44,000 sq ft state-of-the-art facility is adjacent to numerous oncology hospitals in the Bay Area and ~15 minutes from the San Francisco International Airport. Equipped with individual, user-configurable cGMP-production suites, we can support multiple cell lines/multiple products simultaneously due to our unique dedicated HVAC system for each suite.
Capabilities: Cell Therapy Manufacturing Services
Featured site: Allentown, Pennsylvania, USA
Allentown is our largest ambient and cold packaging, storage and distribution facility for clinical trials. The site has expanded services to include commercial packaging with serialization, offering primary packaging of oral solid dose for blister packs and bottles, with additional secondary packaging services for syringe, pre-filled syringe, pen, autoinjector assembly and labeling.
Capabilities: Clinical supply solutions
Featured site: Basel, Switzerland
Our Basel site offers a comprehensive service line supporting all aspects of clinical trial supply - primary and secondary packaging, labeling, regulatory support, distribution, returns and destruction, and comparator sourcing. Additionally the site supports cold chain supplies management and has in-house engineering capabilitites for tooling, equipment customization, and production automation.
Capabilities: Clinical supply solutions